Company Takara Bio Inc.

Equities

4974

JP3460200003

Biotechnology & Medical Research

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Group companies

Sector

Sales per Business

Sales per region

Ratings for Takara Bio Inc.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Biotechnology & Medical Research

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-06-21 EDT			5-day change	1st Jan Change
1,042 ^JPY	+2.56%		+3.37%	-16.77%

03-18	Takara Bio Inc.(TSE:4974) dropped from FTSE All-World Index	CI
02-15	Takara Bio's Attributable Income Falls 98.9% in Fiscal Nine Months	MT

TAKARA BIO INC. is a Japan-based company principally engaged in bio-industry support business and gene medicine business. The Company operates in three business segments. Bioindustry Support segment provides reagents for research (genetic engineering reagents, cell engineering reagents, protein engineering reagents), scientific instruments, contract services and license fees for gene related patents to research institutes, such as universities and companies where biotechnology research and development are conducted. Gene Medicine segment provides gene therapy-related development and sale licensing fees and trial products as an application field of genetic engineering technology and cell engineering technology which is core technology cultivated in development of research reagents. Medical Food and Biotechnology segment provides health food and health food research and development services, license fees for health food related patents, as well as license fees for mushrooms.

Number of employees: 1,793

JPY in Million	2022	Weight	2023	Weight	Delta
Reagent 84.4 %	54,605	80.7 %	65,925	84.4 %	+20.73%
Brokerage 10.5 %	11,426	16.9 %	8,200	10.5 %	-28.23%
Genetic Medicine 3.4 %	148	0.2 %	2,640	3.4 %	+1,683.78%
Equipment 1.8 %	1,518	2.2 %	1,375	1.8 %	-9.42%

JPY in Million	2022	Weight	2023	Weight	Delta
Japan 58.4 %	34,076	50.3 %	45,667	58.4 %	+34.02%
United States 16.5 %	10,186	15.0 %	12,886	16.5 %	+26.51%
China 13.8 %	11,908	17.6 %	10,799	13.8 %	-9.31%
Europe 6.3 %	4,668	6.9 %	4,949	6.3 %	+6.02%
Asia excluding Japan and China 4.5 %	6,614	9.8 %	3,546	4.5 %	-46.39%
Others 0.4 %	244	0.4 %	293	0.4 %	+20.08%

Managers	Title	Age	Since
Shuichiro Matsuzaki DFI	Director of Finance/CFO	68	14-05-31
Koichi Nakao PSD	President	62	02-03-31
Takuya Kakemi ADM	Chief Administrative Officer	-	-
Junichi Mineno COO	Chief Operating Officer	63	04-03-31
Tsuyoshi Miyamura BRD	Director/Board Member	60	08-12-31
Masanobu Kimura BRD	Director/Board Member	60	13-04-30
Noritaka Nishiwaki HRO	Human Resources Officer	-	-
Akihiko Kita AUD	Comptroller/Controller/Auditor	64	05-03-31
Masanari Kitagawa PRN	Corporate Officer/Principal	-	-
Masahide Tamaki AUD	Comptroller/Controller/Auditor	64	05-03-31

Members of the board	Title	Age	Since
Hisashi Omiya CHM	Chairman	81	02-03-31
Masanobu Kimura BRD	Director/Board Member	60	13-04-30
Koichi Nakao PSD	President	62	02-03-31
Shuichiro Matsuzaki DFI	Director of Finance/CFO	68	14-05-31
Tsuyoshi Miyamura BRD	Director/Board Member	60	08-12-31
Junichi Mineno COO	Chief Operating Officer	63	04-03-31
Kazuko Kimura BRD	Director/Board Member	73	19-05-31
Nobuko Kawashima BRD	Director/Board Member	61	16-05-31
Noriomi Matsumura BRD	Director/Board Member	52	20-05-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	0	120,415,600	47,065,600 ( 39.09 %)	0	39.09 %

Name	Equities	%	Valuation
TAKARA HOLDINGS INC. 60.91 %	73,350,000	60.91 %	478 M ¥
DAI-ICHI LIFE HOLDINGS, INC. 0.4182 %	503,600	0.4182 %	3 M ¥
KYOTO FINANCIAL GROUP,INC. 0.4152 %	500,000	0.4152 %	3 M ¥
AllianceBernstein Ltd. 0.2733 %	329,100	0.2733 %	2 M ¥
Sumitomo Mitsui Trust Asset Management Co., Ltd. 0.0652 %	78,500	0.0652 %	511 028 ¥
DJE Kapital AG 0.0558 %	67,227	0.0558 %	437 642 ¥
Dimensional Fund Advisors Ltd. 0.0307 %	37,010	0.0307 %	240 932 ¥
Mercer Global Investments Europe Ltd. 0.0152 %	18,300	0.0152 %	119 131 ¥
Resona Asset Management Co., Ltd. 0.008305 %	10,000	0.008305 %	65 099 ¥
KLP Kapitalforvaltning AS 0.007557 %	9,100	0.007557 %	59 240 ¥

Takara Bio, Inc.

7-4-38 Nojihigashi

525-0058, Kusatsu

+81 77 565 6920

http://www.takara-bio.co.jp

Name	Category and Sector
Cellectis AB Cellectis AB BiotechnologyHealth Technology Part of Takara Holdings, Inc., Cellectis AB is a Swedish company that manufactures and distributes stem cell-related products. The company is based in Gothenburg, Sweden. Cellectis was acquired by Takara Bio, Inc. from Cellectis SA on September 04, 2014.	Biotechnology
Takara Bio Europe SAS Takara Bio Europe SAS Medical SpecialtiesHealth Technology Takara BIO Europe SAS provides kits, reagents, instruments, and services that enable life sciences researchers to achieve their experimental objectives. It offers automation systems, stem cell research, real time PCR, nucleic acid purification, cloning, cell biology assays, gene function, antibodies, and ELISAs. The company is headquartered in Saint-Germain-en-Laye, France.	Medical Specialties

Name

Category and Sector

Biotechnology

Medical Specialties

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1,042 JPY

Average target price

1,567 JPY

Spread / Average Target

+50.35%

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
TAKARA BIO INC.	-16.77%	786M
MODERNA, INC.	+34.14%	51.12B
IQVIA HOLDINGS INC.	-6.54%	39.4B
LONZA GROUP AG	+34.92%	38.48B
CELLTRION, INC.	-12.11%	26.22B
ICON PUBLIC LIMITED COMPANY	+12.62%	26.36B
ALNYLAM PHARMACEUTICALS, INC.	-13.43%	20.96B
UNITED THERAPEUTICS CORPORATION	+43.73%	14.02B
MEDPACE HOLDINGS, INC.	+31.81%	12.49B
BIO-TECHNE CORPORATION	-4.54%	11.61B

Other Biotechnology & Medical Research